Business Context and Reporting Period
This Form 8-K Current Report from iBio, Inc. (a Delaware corporation) covers the date of June 26, 2018. The filing primarily reports the closing of a previously announced public offering of equity securities and the execution of a material amendment to a prior share purchase agreement with a significant shareholder.
Key Financial Metrics and Transaction Details
The filing details the closing of a public offering (the "Offering") on June 26, 2018, structured as follows:
- Common Stock: 4,350,000 shares sold at a public offering price of $0.90 per share.
- Series A Convertible Preferred Stock: 6,300 shares sold at $1,000 per share.
- Series B Convertible Preferred Stock: 5,785 shares sold at $1,000 per share.
The underwriter for the Offering was A.G.P./Alliance Global Partners. The filing does not provide specific revenue, profit, cash flow, or debt metrics for the company's operations, as this is a transactional report rather than a periodic financial statement.
Material Changes and Agreements
Concurrent with the Offering, iBio, Inc. entered into an amendment to its Share Purchase Agreement with Eastern Capital Limited ("Eastern"). Key changes include:
- Beneficial Ownership Limitation: Increased from a maximum of 38% to 48% of the Company's outstanding Common Stock.
- Standstill Provision Extension: The restrictions on Eastern's ability to acquire additional shares were extended until June 26, 2020.
- Authorization: The Board authorized the CEO to offer Eastern shares in the Offering, subject to the new 48% ownership cap (including shares issuable upon conversion of Preferred Stock).
Additionally, the Company filed Certificates of Designation with the Delaware Secretary of State to establish the rights and preferences for the newly created Series A and Series B Convertible Preferred Stock.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or a discussion of general business risks. The primary focus is the legal and structural completion of the capital raise and the modification of shareholder agreements. The filing notes that the description of the Amendment is subject to the full text of the agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the total gross proceeds raised from the Offering by calculating the sum of Common Stock and Preferred Stock sales.
- Review Exhibit 10.1 to understand the full terms of the amended Standstill Provision and any other covenants with Eastern Capital Limited.
- Examine Exhibits 3.1 and 3.2 to confirm the specific conversion rights, liquidation preferences, and voting rights of the Series A and Series B Preferred Stock.
- Confirm the post-offering capital structure to ensure Eastern Capital Limited's ownership remains within the new 48% limit.